Evidence map›Paper›PMID 31017084›Full record

ArticleThe American journal of tropical medicine and hygiene2019

Beyond Blood Smears: Qualification of

Annette M Seilie, Ming Chang, Amelia E Hanron, Zachary P Billman, Brad C Stone, Kevin Zhou, Tayla M Olsen, Glenda Daza, Jose Ortega, Kurtis R Cruz and 28 more

Open access · bronzeAbstract readValidation Study
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Open forum infectious diseases · 2023
    Article
  20. Multi-arm covariate-adaptive randomization.Science China. Mathematics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 10 institutions in 1 country.

Annette M SeilieDepartment of Laboratory Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington.
Ming ChangDepartment of Laboratory Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington.
Amelia E HanronDepartment of Laboratory Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington.
Zachary P BillmanDepartment of Laboratory Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington.
Brad C StoneDepartment of Laboratory Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington.
Kevin ZhouDepartment of Laboratory Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington.
Tayla M OlsenDepartment of Laboratory Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington.
Glenda DazaDepartment of Laboratory Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington.
Jose OrtegaDepartment of Laboratory Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington.
Kurtis R CruzDepartment of Laboratory Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington.
Nahum SmithDepartment of Laboratory Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington.
Sara A HealyLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Jillian NealLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Carolyn K WallisDepartment of Laboratory Medicine, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington.
Lisa SheltonCenter for Global Infectious Disease Research, Seattle Children's Research Institute (formerly the Center for Infectious Disease Research), Seattle, Washington.
Tracie VonGoedert MankowskiCenter for Global Infectious Disease Research, Seattle Children's Research Institute (formerly the Center for Infectious Disease Research), Seattle, Washington.
Sharon Wong-MaddenLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Sebastian A MikolajczakCenter for Global Infectious Disease Research, Seattle Children's Research Institute (formerly the Center for Infectious Disease Research), Seattle, Washington.
Ashley M VaughanCenter for Global Infectious Disease Research, Seattle Children's Research Institute (formerly the Center for Infectious Disease Research), Seattle, Washington.
Stefan H I KappeCenter for Global Infectious Disease Research, Seattle Children's Research Institute (formerly the Center for Infectious Disease Research), Seattle, Washington.
Matt FishbaugherCenter for Global Infectious Disease Research, Seattle Children's Research Institute (formerly the Center for Infectious Disease Research), Seattle, Washington.
Will BetzCenter for Global Infectious Disease Research, Seattle Children's Research Institute (formerly the Center for Infectious Disease Research), Seattle, Washington.
Mark KennedyCenter for Global Infectious Disease Research, Seattle Children's Research Institute (formerly the Center for Infectious Disease Research), Seattle, Washington.
Jen C C HumeLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Angela K TalleyCenter for Global Infectious Disease Research, Seattle Children's Research Institute (formerly the Center for Infectious Disease Research), Seattle, Washington.
Stephen L HoffmanSanaria, Inc., Rockville, Maryland.
Sumana ChakravartySanaria, Inc., Rockville, Maryland.
B Kim Lee SimSanaria, Inc., Rockville, Maryland.
Thomas L RichieSanaria, Inc., Rockville, Maryland.
Anna WaldDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.
Christopher V PloweDuke Global Health Institute, Duke University, Durham, North Carolina.
Kirsten E LykeCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland.
Matthew AdamsCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland.
Gary A FahleMicrobiology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland.
Elliot P CowanPartners in Diagnostics, Rockville, Maryland.
Patrick E DuffyLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
James G KublinSeattle Malaria Clinical Trials Center, Fred Hutch Cancer Research Center, Seattle, Washington.
Sean C MurphyDepartment of Microbiology, University of Washington, Seattle, Washington.
University of Washington · USCenter for Infectious Disease Research · USInfectious Disease Research Institute · USNational Institutes of Health · USSanaria · USUniversity of Maryland, Baltimore · USDuke University · USFred Hutch Cancer Center · USNational Institute of Allergy and Infectious Diseases · USNational Institutes of Health Clinical Center · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Pre-erythrocytic malaria vaccines: Discovery and Clinical DevelopmentZIAAI001135 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DUFFY, PATRICK · 2010 to 2025
$6.4M
PfSPZ Challenge with Chemoprophylaxis: Phase 1 Trial to Assess Liver Stage DrugU01AI109700 · NIAID · SANARIA, INC. · PI DUFFY, PATRICK E, HOFFMAN, STEPHEN LEV · 2013 to 2015
$779k
NIAID NIH HHS P30 AI027757NIAID NIH HHS U01 AI109700
6 · The paper itself

Abstract

18S rRNA is a biomarker that provides an alternative to thick blood smears in controlled human malaria infection (CHMI) trials. We reviewed data from CHMI trials at non-endemic sites that used blood smears and

Indexed as

BiomarkersHumansMalariaMultiplex Polymerase Chain ReactionPlasmodiumReal-Time Polymerase Chain ReactionReproducibility of ResultsReverse Transcriptase Polymerase Chain ReactionRNA, ProtozoanRNA, Ribosomal, 18SBiomarkersRNA, ProtozoanRNA, Ribosomal, 18S

Identifiers

PMID31017084
PMCPMC6553913
OpenAlexW2942487916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.